Our previous study showed that while PEA treatment attenuated multiple aspects of Pcyt2 + /- NASH, it was unable to completely reverse all aberrant mRNA/protein expression [16]. Here, PCYT2 is linked to metabolic dysfunction-associated steatohepatitis.